Altogether, resveratrol represents an important natural NF-κB and thus inflammation inhibitor, as it is able to simultaneously activate the tumor protein p53 and p53-associated downstream target genes, which can lead to inhibition of cell plasticity [14], a fact that is particularly relevant in CRC therapy. This evidence concerns the gene TP53 and colorectal carcinoma.